STOCK TITAN
  1. Home
  2. Sec-filings
  3. HIMS
  4. [Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Hims & Hers (HIMS) CFO sells 54,927 shares under 10b5-1 plan

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe reported option exercises and share sales under a pre-arranged Rule 10b5-1 trading plan. On April 16–17, Okupe sold a total of 54,927 shares of Class A Common Stock in open-market transactions at average prices of $25.8964 and $27.8344. He also exercised stock options for 6,184 shares at an exercise price of $5.01 per share, converting derivative awards into common stock. Following these transactions, Okupe holds 270,046 shares directly and 7,853 shares indirectly through the Oluyemi Okupe Separate Property Trust, and retains stock options representing 129,403 shares expiring on February 23, 2032.

Positive

  • None.

Negative

  • None.
Insider Okupe Oluyemi
Role Chief Financial Officer
Sold 54,927 shs ($1.46M)
Type Security Shares Price Value
Exercise Stock Option (right to buy) 6,184 $0.00 --
Exercise Class A Common Stock 6,184 $5.01 $31K
Sale Class A Common Stock 18,005 $27.8344 $501K
Sale Class A Common Stock 36,922 $25.8964 $956K
holding Class A Common Stock -- -- --
Holdings After Transaction: Stock Option (right to buy) — 129,403 shares (Direct, null); Class A Common Stock — 288,051 shares (Direct, null); Class A Common Stock — 7,853 shares (Indirect, Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021)
Footnotes (1)
  1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.74-$26.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.70-$27.97. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
Shares sold 54,927 shares Total Class A Common Stock sold on April 16–17, 2026
Sale price April 16 $25.8964/share Weighted-average price for 36,922 shares sold April 16, 2026
Sale price April 17 $27.8344/share Weighted-average price for 18,005 shares sold April 17, 2026
Options exercised 6,184 shares Stock options converted to Class A Common Stock on April 17, 2026
Option exercise price $5.01/share Exercise price for stock options converted on April 17, 2026
Direct holdings after trades 270,046 shares Direct Class A Common Stock owned by CFO after April 17, 2026
Indirect holdings (trust) 7,853 shares Class A Common Stock held by Separate Property Trust as of April 16, 2026
Remaining options 129,403 shares Stock options outstanding after exercise, expiring February 23, 2032
Rule 10b5-1 trading plan regulatory
"were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
average weighted price financial
"Price reported constitutes the average weighted price of shares sold."
Separate Property Trust financial
"Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021"
vesting financial
"25% of the options will vest on the twelve (12) month anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Okupe Oluyemi
(Last)(First)(Middle)
2269 CHESTNUT STREET, #523
(Street)
SAN FRANCISCO CALIFORNIA 94123
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock04/16/2026S(1)36,922D$25.8964(2)281,867D
Class A Common Stock04/17/2026M(1)6,184A$5.01288,051D
Class A Common Stock04/17/2026S(1)18,005D$27.8344(3)270,046D
Class A Common Stock7,853IHeld by Oluyemi Okupe Separate Property Trust dtd 9-1-2021
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$5.0104/17/2026M(1)6,184 (4)02/23/2032Class A Common Stock6,184$0129,403D
Explanation of Responses:
1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.74-$26.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.70-$27.97. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
4. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe04/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did HIMS CFO Oluyemi Okupe report on this Form 4?

Oluyemi Okupe reported open-market sales of Class A Common Stock and an option exercise. He sold 54,927 shares over April 16–17 and exercised stock options for 6,184 shares, converting them into common stock as part of his equity compensation.

How many Hims & Hers (HIMS) shares did the CFO sell and at what prices?

The CFO sold 54,927 Class A Common shares in total. He sold 36,922 shares at an average price of $25.8964 and 18,005 shares at an average price of $27.8344, according to weighted-average price disclosures in the filing’s footnotes.

Were the HIMS CFO’s stock sales made under a Rule 10b5-1 trading plan?

Yes. The filing states the option exercises and sales were effected under a Rule 10b5-1 trading plan adopted on May 21, 2025. Such plans pre-schedule trades, indicating these transactions were arranged in advance rather than timed opportunistically by the executive.

What stock options did the Hims & Hers CFO exercise in this Form 4?

Okupe exercised stock options covering 6,184 shares of Class A Common Stock at a $5.01 exercise price. These options are part of a grant vesting over four years, with 25% vesting after 12 months and the remainder in 36 equal monthly installments.

How many Hims & Hers (HIMS) shares does the CFO hold after these transactions?

After the reported trades, the CFO holds 270,046 shares of Class A Common Stock directly. He also holds 7,853 additional shares indirectly through the Oluyemi Okupe Separate Property Trust, as reflected in the indirect ownership line dated April 16, 2026.

What option position does the HIMS CFO retain following the reported exercise?

Following the exercise of 6,184 options, the CFO still holds stock options for 129,403 shares. These options relate to Class A Common Stock with an exercise price of $5.01 per share and an expiration date of February 23, 2032, providing long-dated equity exposure.